Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter E, Parts 101-124

Forms and Documents

Document Name	Status

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Document Title	Status
2082	Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter E, Parts 101-124 Form	Migrated

ICR Details

OMB Control No: 0579-0013	ICR Reference No: 199903-0579-003
Status: Historical Inactive	Previous ICR Reference No: 199806-0579-001
Agency/Subagency: USDA/APHIS	Agency Tracking No:
Title: Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter E, Parts 101-124
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Comment filed on proposed rule and continue	Conclusion Date: 04/27/1999
	Date Received in OIRA: 03/24/1999
Terms of Clearance: Before publication of the final rule, the agency will provide to OMB a summary of the comments related to the burden imposed by the rule. As necessary, the agency should revise its estimate of burden based on comments. The agency shall also review its estimate of burden, keeping in mind that labeling requirements are subject to the PRA and the burden associated with these disclosures to the public must be approved by OMB.(5 CFR 1320.3)

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2001	09/30/2001	09/30/2001
Responses	31,767	0	31,767
Time Burden (Hours)	71,547	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: Collection of information under the Virus-Serum-Toxin (VST) Act is from all entities importing or shipping veterinary biological products to, from, or in the United States. Responses are from licensed manufacturers, infrequently individuals, and institutions. The information is used to execute the congressional intent of the VST Act and regulations.

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter E, Parts 101-124	APHIS-FORM-2015

---

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/24/1999

---